These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29748937)

  • 1. Switching benefits and costs in the Irish health insurance market: an analysis of consumer surveys.
    Keegan C; Teljeur C; Turner B; Thomas S
    Int J Health Econ Manag; 2019 Mar; 19(1):15-32. PubMed ID: 29748937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching benefits and costs in competitive health insurance markets: A conceptual framework and empirical evidence from the Netherlands.
    Duijmelinck DM; Mosca I; van de Ven WP
    Health Policy; 2015 May; 119(5):664-71. PubMed ID: 25530069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching insurer in the Irish voluntary health insurance market: determinants, incentives, and risk equalization.
    Keegan C; Teljeur C; Turner B; Thomas S
    Eur J Health Econ; 2016 Sep; 17(7):823-31. PubMed ID: 26359243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why do people not switch insurer in a market-based health insurance market? Empirical evidence from the Netherlands.
    van der Schors W; Brabers AEM; de Jong JD
    Eur J Public Health; 2020 Aug; 30(4):633-638. PubMed ID: 32236545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Dutch health insurance reform: switching between insurers, a comparison between the general population and the chronically ill and disabled.
    de Jong JD; van den Brink-Muinen A; Groenewegen PP
    BMC Health Serv Res; 2008 Mar; 8():58. PubMed ID: 18366678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supplementary insurance as a switching cost for basic health insurance: Empirical results from the Netherlands.
    Willemse-Duijmelinck DMID; van de Ven WPMM; Mosca I
    Health Policy; 2017 Oct; 121(10):1085-1092. PubMed ID: 28855064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching rates in health insurance markets decrease with age: empirical evidence and policy implications from the Netherlands.
    Duijmelinck DM; van de Ven WP
    Health Econ Policy Law; 2016 Apr; 11(2):141-59. PubMed ID: 26173559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching health insurance plans: results from a health survey.
    Lako CJ; Rosenau P; Daw C
    Health Care Anal; 2011 Dec; 19(4):312-28. PubMed ID: 20640891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keeping competition fair for health insurance: how the Irish beat back risk-rated policies.
    Light DW
    Am J Public Health; 1998 May; 88(5):745-8. PubMed ID: 9585738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulated competition in health care: switching and barriers to switching in the Dutch health insurance system.
    Reitsma-van Rooijen M; de Jong JD; Rijken M
    BMC Health Serv Res; 2011 May; 11():95. PubMed ID: 21569225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of supplementary health insurance on switching behaviour: evidence from Swiss data.
    Dormont B; Geoffard PY; Lamiraud K
    Health Econ; 2009 Nov; 18(11):1339-56. PubMed ID: 19267356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching health insurers: the role of price, quality and consumer information search.
    Boonen LH; Laske-Aldershof T; Schut FT
    Eur J Health Econ; 2016 Apr; 17(3):339-53. PubMed ID: 25820635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community rating in the absence of risk equalisation: lessons from the Irish private health insurance market.
    Turner B; Shinnick E
    Health Econ Policy Law; 2013 Apr; 8(2):209-24. PubMed ID: 22717020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choice determinants of the mobility in the Dutch health insurance market.
    Mosca I; Schut-Welkzijn A
    Eur J Health Econ; 2008 Aug; 9(3):261-4. PubMed ID: 17851703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching costs in competitive health insurance markets: The role of insurers' pricing strategies.
    Lamiraud K; Stadelmann P
    Health Econ; 2020 Sep; 29(9):992-1012. PubMed ID: 32542729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The introduction of lifetime community rating in the Irish private health insurance market: Effects on coverage and plan choice.
    Keegan C
    Soc Sci Med; 2020 Jun; 255():113006. PubMed ID: 32387872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching gains and health plan price elasticities: 20 years of managed competition reforms in The Netherlands.
    Douven R; Katona K; T Schut F; Shestalova V
    Eur J Health Econ; 2017 Nov; 18(8):1047-1064. PubMed ID: 28243775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumer mobility in social health insurance markets : a five-country comparison.
    Laske-Aldershof T; Schut E; Beck K; Gress S; Shmueli A; Van de Voorde C
    Appl Health Econ Health Policy; 2004; 3(4):229-41. PubMed ID: 15901197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The key role of health insurance in a cost-effective health care system. Towards regulated competition in the Dutch medical market.
    van de Ven WP
    Health Policy; 1987 Apr; 7(2):253-72. PubMed ID: 10312077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the chronically ill population in the Netherlands switch their health insurer as often as the general population? Empirical evidence from a nationwide survey study.
    van der Schors W; Brabers AEM; De Jong JD
    BMC Health Serv Res; 2020 May; 20(1):376. PubMed ID: 32370798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.